title: Scintigraphic visualization of ocular melanoma with Tc-99m glutathione.
abstract: In a patient with ocular melanoma scintigraphy obtained with 99mTc-GSH clearly demonstrated the histologically proven ocular lesion both in planar and SPECT images. 99mTc-sestamibi study obtained in the same patient three days later was negative. 99mTc-GSH is a potential alternative to the currently used radiopharmaceuticals for imaging both cutaneous and ocular melanomas and their metastases.
authors.affiliation: Department of Nuclear Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Tutuş
authors.forename: K
authors.initials: K
authors.lastname: Erkiliç
authors.forename: M T
authors.initials: MT
authors.lastname: Ercan
authors.forename: O
authors.initials: O
authors.lastname: Kontaş
authors.forename: M
authors.initials: M
authors.lastname: Aydin
authors.forename: H
authors.initials: H
authors.lastname: Doğan
mesh_terms: D005134:Eye Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D005978:Glutathione / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging* / Q000473:pathology; D008875:Middle Aged; D013667:Technetium; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
chemical_list: C090285:technetium Tc 99m glutathione; D013667:Technetium; D017256:Technetium Tc 99m Sestamibi; D005978:Glutathione